증권사 리포트&코멘트
ASCO 2026 국내 주요 기업 Abstract 타이틀
Text 공개는 5/21
[Oral Abstract]
Johnson&Johnson CHRYSALIS-2
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17108?presentation=260413
[Rapid Oral Abstract]
지아이이노베이션 GI-101A
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17133?presentation=258023
[Poster]
보로노이 VRN11, VRN10
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17110?presentation=265950
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17083?presentation=261223
티움바이오 tosposertib
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17134?presentation=257875
온코닉테라퓨틱스 nesuparib
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17143?presentation=267805
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17143?presentation=266897
이뮨온시아 IMC-002
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17134?presentation=257762
에스티큐브 nelmastobart
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17140?presentation=262275
온코크로스 HCQ and CPC
https://meetings.asco.org/meetings/2026-asco-annual-meeting/335/17143?presentation=264007
지놈앤컴퍼니 EP0089
https://www.asco.org/abstracts-presentations/266814
*제보 환영
meetings.asco.org
ASCO Meetings
ASCO Meetings Program Guide
외부 자료를 정리한 참고자료이며 투자 권유가 아닙니다. 기사·리포트의 저작권은 원저작자에게 있습니다. · 게시중단 요청